Cargando…

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales

Phenotypic testing for Enterobacterales that harbour ESBLs is not additive to accurate in vitro β-lactam MICs for clinical decision-making. ESBL testing is an outdated practice established in an era of higher cephalosporin breakpoints to prevent resistant Enterobacterales carrying Ambler class A β-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathers, Amy J, Lewis, James S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	For Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210140/ https://www.ncbi.nlm.nih.gov/pubmed/34223109 http://dx.doi.org/10.1093/jacamr/dlab020

Ejemplares similares

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress
por: Tamma, Pranita D, et al.
Publicado: (2021)

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021)

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales
por: Paterson, David L, et al.
Publicado: (2021)

Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases
por: Noster, Janina, et al.
Publicado: (2021)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

ESBL Activity, MDR, and Carbapenem Resistance among Predominant Enterobacterales Isolated in 2019
por: Bandy, Altaf, et al.
Publicado: (2021)

Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Moghekar, Abhay, et al.
Publicado: (2012)

1839. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia
por: Steere, Evan, et al.
Publicado: (2022)

No space left for intravenous thrombolysis in acute stroke: CONS
por: Muir, Keith
Publicado: (2016)

Pros and cons of a prion-like pathogenesis in Parkinson's disease
por: Hilker, Ruediger, et al.
Publicado: (2011)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the “con” view
por: Ginsberg, David N., et al.
Publicado: (2016)

Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!
por: Drewes, Asbjørn Mohr, et al.
Publicado: (2019)

Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers
por: Andremont, Olivier, et al.
Publicado: (2020)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

Monitoring of Non-β-Lactam Antibiotic Resistance-Associated Genes in ESBL Producing Enterobacterales Isolates
por: Shinu, Pottathil, et al.
Publicado: (2020)

Developmental trauma disorder: pros and cons of including formal criteria in the psychiatric diagnostic systems
por: Schmid, Marc, et al.
Publicado: (2013)

Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
por: Head, Elizabeth, et al.
Publicado: (2014)

Debates in Allergy Medicine: Oral immunotherapy shortens the duration of milk and egg allergy - the con argument
por: Loh, Wenyin, et al.
Publicado: (2018)

Approaches to informed consent for hypothesis-testing and hypothesis-generating clinical genomics research
por: Facio, Flavia M, et al.
Publicado: (2012)

Is shorter always better? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics
por: Yahav, Dafna, et al.
Publicado: (2022)

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States
por: Tamma, Pranita D, et al.
Publicado: (2019)

Navigating treatment approaches for presumed ESBL-producing infections
por: Tamma, Pranita D, et al.
Publicado: (2021)

CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy
por: Howard, Alex, et al.
Publicado: (2022)

A Commitment to HIV Diagnostic Accuracy – a comment on “Towards more accurate HIV testing in sub‐Saharan Africa: a multi‐site evaluation of HIV RDTs and risk factors for false positives ‘and’ HIV misdiagnosis in sub‐Saharan Africa: a performance of diagnostic algorithms at six testing sites”
por: Kravitz Del Solar, Amy S, et al.
Publicado: (2018)

Formulating productive marketing communications strategy: a major health system’s experience
por: Elrod, James K., et al.
Publicado: (2018)

A Chiropracticness Test
por: Charlton, Keith H
Publicado: (2005)

The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review
por: Mai, Ha Thi Thao, et al.
Publicado: (2023)

Personal genome testing: Test characteristics to clarify the discourse on ethical, legal and societal issues
por: Bunnik, Eline M, et al.
Publicado: (2011)

Occurrence, Typing, and Resistance Genes of ESBL/AmpC-Producing Enterobacterales in Fresh Vegetables Purchased in Central Israel
por: Kon, Hadas, et al.
Publicado: (2023)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Mucopolysaccharidosis VI in cats – clarification regarding genetic testing
por: Lyons, Leslie A., et al.
Publicado: (2016)

Significance testing as perverse probabilistic reasoning
por: Westover, M Brandon, et al.
Publicado: (2011)

Baseline testing in cluster randomised controlled trials: should this be done?
por: Bolzern, Jaime E., et al.
Publicado: (2019)

One statistical test is sufficient for assessing new predictive markers
por: Vickers, Andrew J, et al.
Publicado: (2011)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2021)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vj6f6sojqmafgabnpbln1ftbfk